A critical advance in cancer investigation is arising with the use of mini-antibodies to restore dysfunctional p53. This essential malignant inhibitor protein is frequently disabled in various forms of tumors, causing https://doctorbookmark.com/story22009941/vhh-fragments-revive-the-p53-protein-new-promising-pathway-for-tumor-therapy